Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
NetApp | NTAP | 14. jan 2025 | 116.69 | +1.54 |
Netcapital | NCPL | 14. jan 2025 | 1.72 | -6.01 |
Netclass Technology | NTCL | 14. jan 2025 | 7.40 | 0.00 |
NetEase ADR | NTES | 14. jan 2025 | 96.03 | +1.89 |
Netflix | NFLX | 14. jan 2025 | 828.40 | -1.42 |
NETGEAR | NTGR | 14. jan 2025 | 26.28 | +1.31 |
Netherlands Invstbl Mkt Idx MSCI Ishares | EWN | 14. jan 2025 | 44.70 | +0.97 |
NetScout Systems | NTCT | 14. jan 2025 | 21.93 | +2.57 |
NETSOL Technologies | NTWK | 14. jan 2025 | 2.60 | 0.00 |
Netstreit | NTST | 14. jan 2025 | 13.86 | +0.36 |
Network-1 Technologies | NTIP | 14. jan 2025 | 1.39 | -2.11 |
Neuberger Berman | NML | 14. jan 2025 | 9.13 | +2.13 |
Neuberger Berman High Yield Strategies Fund | NHS | 14. jan 2025 | 7.59 | -0.33 |
Neuberger Berman Municipal Fund | NBH | 14. jan 2025 | 10.18 | +0.39 |
Neuberger Berman Next Generation Connectivity Fund | NBXG | 14. jan 2025 | 12.83 | -0.54 |
Neuberger Berman Real Estate Securities Income Fund | NRO | 14. jan 2025 | 3.50 | -0.14 |
NeueHealth | NEUE | 14. jan 2025 | 7.36 | +0.82 |
Neumora Therapeutics | NMRA | 14. jan 2025 | 2.28 | -5.79 |
Neuphoria Therapeutics | NEUP | 14. jan 2025 | 3.20 | 0.00 |
Neuraxis | NRXS | 14. jan 2025 | 2.52 | -0.79 |
Neurobo Pharmaceuticals | NRBO | 14. jan 2025 | 2.36 | 0.00 |
Neurocrine Biosciences | NBIX | 14. jan 2025 | 139.51 | -2.46 |
Neurogene | NGNE | 14. jan 2025 | 17.89 | -4.89 |
NeuroMetrix | NURO | 14. jan 2025 | 3.98 | -0.79 |
Neuronetics | STIM | 14. jan 2025 | 2.16 | -7.69 |
NeuroOne | NMTC | 14. jan 2025 | 1.11 | -1.05 |
Neuropace | NPCE | 14. jan 2025 | 11.84 | -2.23 |
NeuroSense Therapeutics | NRSN | 14. jan 2025 | 1.03 | -0.60 |
Nevro | NVRO | 14. jan 2025 | 3.70 | -8.19 |
New America High Income Fund | HYB | 14. jan 2025 | 8.23 | +0.24 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.